Rationale and design of the CV-PREVITAL study: an Italian multiple cohort randomised controlled trial investigating innovative digital strategies in primary cardiovascular prevention
Damiano Baldassarre,Licia Iacoviello,Roberta Baetta,Maria Carla Roncaglioni,Gianluigi Condorelli,Giuseppe Remuzzi,Gianfranco Gensini,Luigi Frati,Walter Ricciardi,Pier Giulio Conaldi,Antonio Uccelli,Fabio Blandini,Silvano Bosari,Giovanni Scambia,Massimo Fini,Antonio Di Malta,Mauro Amato,Fabrizio Veglia,Alice Bonomi,Catherine Klersy,Francesca Colazzo,Martino Pengo,Francesca Gorini,Luciana Auteri,Giuseppe Ferrante,Marta Baviera,Giuseppe Ambrosio,Alberico Catapano,Alessandro Gialluisi,Alexis Elias Malavazos,Serenella Castelvecchio,Massimiliano Marco Corsi-Romanelli,Rosanna Cardani,Maria Teresa La Rovere,Valentina Agnese,Bianca Pane,Daniele Prati,Laura Spinardi,Giovanna Liuzzo,Eloisa Arbustini,Maurizio Volterrani,Marco Visconti,José Pablo Werba,Stefano Genovese,Grzegorz Bilo,Cecilia Invitti,Anna Di Blasio,Carolina Lombardi,Andrea Faini,Debora Rosa,Luisa Ojeda-Fernández,Andreana Foresta,Amalia De Curtis,Augusto Di Castelnuovo,Simonetta Scalvini,Antonia Pierobon,Alessandra Gorini,Luca Valenti,Livio Luzi,Annarosa Racca,Manuela Bandi,Elena Tremoli,Lorenzo Menicanti,Gianfranco Parati,Giulio Pompilio,CV-PREVITAL Study Group,Gualtiero Colombo,Chiara Vavassori,Maria Luisa Biondi,Beatrice Frigerio,Alessio Ravani,Daniela Sansaro,Daniela Coggi,Alessandra Romandini,Monica Giroli,Mattia Giuliani,Maurizio Rondinelli,Catia Trudu,Carmen Cinieri,Massimo Monturano,Camilla Torlasco,Luisa Gilardini,Davide Soranna,Antonella Zambon,Elisa Perger,Lucia Zanotti,Luigi Badano,Lidia Cova,Davide Gentilini,Luca Grappiolo,Laura Papa,Victor Savevski,Francesca Ieva,Ignazio Romano,Luisa Ojeda,Fiorenza Clerici,Angela Palumbo,Gian Franco Gensini,Roberto Mattioli,Ermanno Longhi,Lorenzo Giovanni Mantovani,Fabiana Madotto,Marialaura Bonaccio,Francesco Gianfagna,Anwal Ghulam,Sara Magnacca,Fabrizia Noro,Simona Costanzo,Simona Esposito,Sabatino Orlandi,Mariarosaria Persichillo,Francesca Bracone,Teresa Panzera,Emilia Ruggiero,Roberta Parisi,Sabrina Franciosa,Martina Morelli,Fiorella De Rita,Chiara Cerletti,Giovanni de Gaetano,Maria Benedetta Donati,Massimiliano MarcoCorsi Romanelli,Ambra Cerri,Carola Dubini,Manuel Bruno Trevisan,Laura Valentina Renna,Valentina Milani,Sara Boveri,Paola Giubbilini,Lucia Ramputi,Irene Baroni,Giada DeAngeli,Francesca Olmetti,Maurizio Bussotti,Carlo Gaetano,Paola Baiardi,Tiziana Bachetti,Martina Balbi,Laura Comini,Monica Lorenzoni,Adriana Olivares,Egidio Traversi,Camilla Garrè,Riccardo Sideri,Francesco Clemenza,Giovanni Gentile,Giuseppe Caruana,Nicola Cuscino,Gabriele Di Gesaro,Alessio Greco,Italia Loddo,Fabio Tuzzolino,Domenico Palombo,Giovanni Spinella,Gaddiel Mozzetta,Pietro Ameri,Gabriele Zoppoli,Alice Finotello,Italo Porto,Giovanni Pratesi,Margherita Clerici,Serena Pelusi,Cristiana Bianco,Rossana Carpani,Giulia Periti,Sara Margarita,Gaetano Antonio Lanza,Anna Severino,Daniela Pedicino,Domenico D'Amario,Alessia D'Aiello,Ramona Vinci,Alice Bonanni,Mattia Brecciaroli,Simone Filomia,Roberta Pastorino,Stefania Boccia,Andrea Urbani,Maurizio Sanguinetti,Angelo Santoliquido,Luca Proto,Dalila Tarquini,Maria Chiara Grimaldi,Sergio Leonardi,Arianna Elia,Alessia Currao,Mario Urtis,Alessandro Di Toro,Lorenzo Giuliani,Giuseppe Caminiti,Federica Marcolongo,Barbara Sposato,Fiorella Guadagni,Valentina Morsella,Angelica Marziale,Giulia Protti
DOI: https://doi.org/10.1136/bmjopen-2023-072040
IF: 3.006
2023-07-14
BMJ Open
Abstract:Introduction: Prevention of cardiovascular disease (CVD) is of key importance in reducing morbidity, disability and mortality worldwide. Observational studies suggest that digital health interventions can be an effective strategy to reduce cardiovascular (CV) risk. However, evidence from large randomised clinical trials is lacking. Methods and analysis: The CV-PREVITAL study is a multicentre, prospective, randomised, controlled, open-label interventional trial designed to compare the effectiveness of an educational and motivational mobile health (mHealth) intervention versus usual care in reducing CV risk. The intervention aims at improving diet, physical activity, sleep quality, psycho-behavioural aspects, as well as promoting smoking cessation and adherence to pharmacological treatment for CV risk factors. The trial aims to enrol approximately 80 000 subjects without overt CVDs referring to general practitioners' offices, community pharmacies or clinics of Scientific Institute for Research, Hospitalization and Health Care (Italian acronym IRCCS) affiliated with the Italian Cardiology Network. All participants are evaluated at baseline and after 12 months to assess the effectiveness of the intervention on short-term endpoints, namely improvement in CV risk score and reduction of major CV risk factors. Beyond the funded life of the study, a long-term (7 years) follow-up is also planned to assess the effectiveness of the intervention on the incidence of major adverse CV events. A series of ancillary studies designed to evaluate the effect of the mHealth intervention on additional risk biomarkers are also performed. Ethics and dissemination: This study received ethics approval from the ethics committee of the coordinating centre (Monzino Cardiology Center; R1256/20-CCM 1319) and from all other relevant IRBs and ethics committees. Findings are disseminated through scientific meetings and peer-reviewed journals and via social media. Partners are informed about the study's course and findings through regular meetings. Trial registration number: NCT05339841.